BCTXL

NASD BriaCell Therapeutics Corp. - Warrants
Nov 14, 2026 · 6:42 PM ET EOD Market Closed

$0.8708 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.8708, $0.1092 below the day’s high of $0.9800

YTD change
-6.37%
vs 20-day SMA
-1.93%
vs 200-day SMA
-10.17%

Price ranges

Previous day
$0.8707 $0.9800
open $0.9000 close $0.8708
-$0.0292 (-3.24%)
Today
$0.8707 $0.9800
$0.8708
Past week
$0.8100 $1.0500
from $0.8100 now $0.8708
+$0.0608 (+7.51%)
Past month
$0.7000 $1.0500
from $0.8879 now $0.8708
-$0.0171 (-1.93%)
This year
$0.6100 $1.4000
from $0.9300 now $0.8708
-$0.0592 (-6.37%)

Price & Performance

-0.24 (-21.55%) / 6M

$0.6035$0.8278$1.05$1.28May 14Aug 19Nov 13

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 37.8% away from all-time highs of $1.4000
  • BCTXL is down 6% since the beginning of the year
  • BCTXL is down 6% over the past 12 months
  • BCTXL is down 2% over the past 1 month

BCTXL reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -6.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap N/A

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $465.67 -0.30%
MRNA Moderna, Inc. $223.37 -3.45%
RVMD Revolution Medicines, Inc. $172.29 -2.30%
ROIV Roivant Sciences Ltd. $39.53 -1.15%
BNTX BioNTech SE Sponsored ADR $85.60 +0.66%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.